Table 2.
Prevalence Ratios for CAH by Age and Sex for the Commercial and Medicaid Samples
Met Criteria for CAH | ||||
---|---|---|---|---|
Prevalence | PR | 95% CI | P Value | |
Commercial sample | ||||
All | 1:9906 | |||
Age | ||||
5-11 y (reference) | 1:10 066 | 1 | ||
12-18 y | 1:9769 | 1.03 | (0.84-1.26) | 0.773 |
Sex | ||||
Boys (reference) | 1:11 166 | 1 | ||
Girls | 1:8891 | 1.26 | (1.02-1.54) | 0.029 |
Medicaid sample | ||||
All | 1:13 905 | |||
Age | ||||
5-11 y (reference) | 1:13 390 | 1 | ||
12-18 y | 1:14 662 | 0.91 | (0.71-1.18) | 0.484 |
Sex | ||||
Boys (reference) | 1:17 303 | 1 | ||
Girls | 1:11 593 | 1.49 | (1.16-1.92) | 0.002 |
Prevalence ratio (PR), confidence interval (CI), years (y), reference category (Ref). P-values represent chi-square tests.
Abbreviations: CAH, congenital adrenal hyperplasia; PR, prevalence ratio.